Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations.
other · Level III
Where this comes from
- Record sourced from PubMed, PMID 35234883.
- Also identified by DOI 10.1001/jamanetworkopen.2022.0868 and PMC identifier 8892225.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This comparative effectiveness research study examines the effectiveness of full vaccination with Ad26.COV2.S vs BNT162b2 against COVID-19–related hospitalization.
Medical subject headings
- Ad26COVS1
- BNT162 Vaccine
- COVID-19
- COVID-19 Vaccines
- Hospitalization
- SARS-CoV-2
- Vaccine Efficacy